Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (391-400 of 554) with videos related to

Pageof 56
Sort By:
Neurology|September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PETSuzanne E Schindler, Yan Li, Virginia D Buckles, et al.
Brain : a Journal of Neurology|May 29, 2012
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-βRobert M Koffie, Tadafumi Hashimoto, Hwan-Ching Tai, et al.
Science Translational Medicine|February 18, 2021
APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular functionMonica Xiong, Hong Jiang, Javier Remolina Serrano, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 27, 2006
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolismKe-Jie Yin, John R Cirrito, Ping Yan, et al.
Journal of Alzheimer'S Disease : JAD|April 26, 2012
Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's diseaseErik Portelius, Henrik Zetterberg, Robert A Dean, et al.
The Journal of Experimental Medicine|February 28, 2018
ApoE facilitates the microglial response to amyloid plaque pathologyJason D Ulrich, Tyler K Ulland, Thomas E Mahan, et al.
Brain : a Journal of Neurology|October 11, 2018
Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkersCatherine M Roe, Beau M Ances, Denise Head, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 miceByung Hee Han, Meng-Liang Zhou, Andrew W Johnson, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
The Journal of Clinical Investigation|October 22, 2005
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse modelJohn R Cirrito, Rashid Deane, Anne M Fagan, et al.
Pageof 56

Showing results (391-400 of 554) with videos related to

Sort By:
Pageof 56
Neurology|September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PETSuzanne E Schindler, Yan Li, Virginia D Buckles, et al.
Brain : a Journal of Neurology|May 29, 2012
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-βRobert M Koffie, Tadafumi Hashimoto, Hwan-Ching Tai, et al.
Science Translational Medicine|February 18, 2021
APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular functionMonica Xiong, Hong Jiang, Javier Remolina Serrano, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 27, 2006
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolismKe-Jie Yin, John R Cirrito, Ping Yan, et al.
Journal of Alzheimer'S Disease : JAD|April 26, 2012
Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's diseaseErik Portelius, Henrik Zetterberg, Robert A Dean, et al.
The Journal of Experimental Medicine|February 28, 2018
ApoE facilitates the microglial response to amyloid plaque pathologyJason D Ulrich, Tyler K Ulland, Thomas E Mahan, et al.
Brain : a Journal of Neurology|October 11, 2018
Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkersCatherine M Roe, Beau M Ances, Denise Head, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 miceByung Hee Han, Meng-Liang Zhou, Andrew W Johnson, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
The Journal of Clinical Investigation|October 22, 2005
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse modelJohn R Cirrito, Rashid Deane, Anne M Fagan, et al.
Pageof 56